151![Australian & New Zealand Bone & Mineral Society Issue 13 inside this issue Australian & New Zealand Bone & Mineral Society Issue 13 inside this issue](https://www.pdfsearch.io/img/367ff0926bf0aebe4628856635d0a69c.jpg) | Add to Reading ListSource URL: www.anzbms.org.auLanguage: English - Date: 2015-02-22 22:52:46
|
---|
152![Genetic engineering / Bioengineering / Emerging technologies / Genetically modified organism / Therapeutic Goods Administration / Agriculture / GMO / Biology / Molecular biology / Biotechnology Genetic engineering / Bioengineering / Emerging technologies / Genetically modified organism / Therapeutic Goods Administration / Agriculture / GMO / Biology / Molecular biology / Biotechnology](/pdf-icon.png) | Add to Reading ListSource URL: www.ogtr.gov.auLanguage: English - Date: 2015-03-06 01:48:49
|
---|
153![Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Oncologic Drugs Advisory Committee Meeting January 7, 2015 Location: FDA White Oak Campus, Building 31, the Great Room, White Oa Food and Drug Administration Center for Drug Evaluation and Research Summary Minutes of the Oncologic Drugs Advisory Committee Meeting January 7, 2015 Location: FDA White Oak Campus, Building 31, the Great Room, White Oa](https://www.pdfsearch.io/img/82b6bfc16962164fda262674aaef758d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
154![NOTIFICATION OF APPLICATION Receipt of licence application (DIR 132) from Amgen Australia Pty Ltd for the commercial release of a tumour-selective genetically modified organism for cancer therapy Application The Office o NOTIFICATION OF APPLICATION Receipt of licence application (DIR 132) from Amgen Australia Pty Ltd for the commercial release of a tumour-selective genetically modified organism for cancer therapy Application The Office o](https://www.pdfsearch.io/img/4056e23694bfd9163f9ec3f5fe185b84.jpg) | Add to Reading ListSource URL: www.ogtr.gov.auLanguage: English - Date: 2015-03-06 01:37:31
|
---|
155![ANZBMS – 25 September 2014 e-Newsletter ANZBMS e-News 25 September[removed]ASBMR Young Investigator Award ANZBMS – 25 September 2014 e-Newsletter ANZBMS e-News 25 September[removed]ASBMR Young Investigator Award](https://www.pdfsearch.io/img/c9f271169956be3cd93aa8c538b3ff9e.jpg) | Add to Reading ListSource URL: www.anzbms.org.auLanguage: English - Date: 2015-02-22 23:10:40
|
---|
156![PATIENT INFORMATION ON DENOSUMAB Brand name: Prolia This information sheet has been produced by the Australian Rheumatology Association to help PATIENT INFORMATION ON DENOSUMAB Brand name: Prolia This information sheet has been produced by the Australian Rheumatology Association to help](https://www.pdfsearch.io/img/19bbb32bb46f2d490985581034c50e0b.jpg) | Add to Reading ListSource URL: www.rheumatology.org.auLanguage: English - Date: 2014-01-16 18:36:35
|
---|
157![Bekanntmachung zu den Endgültigen Bedingungen vom[removed]für UBS Turbo Call/Put Optionsscheine mit den nachfolgenden ISINs bezogen auf den Kurs der Aktie der Alibaba Group Holding Limited CH0271423300 Bekanntmachung zu den Endgültigen Bedingungen vom[removed]für UBS Turbo Call/Put Optionsscheine mit den nachfolgenden ISINs bezogen auf den Kurs der Aktie der Alibaba Group Holding Limited CH0271423300](https://www.pdfsearch.io/img/02bdd2ca92d9da07400e95630c94096f.jpg) | Add to Reading ListSource URL: keyinvest-at.ubs.comLanguage: English - Date: 2015-03-08 16:16:20
|
---|
158![Bekanntmachung zu den Endgültigen Bedingungen vom[removed]für UBS Turbo Call/Put Optionsscheine mit den nachfolgenden ISINs bezogen auf den Kurs der Aktie der Alibaba Group Holding Limited CH0271423300 Bekanntmachung zu den Endgültigen Bedingungen vom[removed]für UBS Turbo Call/Put Optionsscheine mit den nachfolgenden ISINs bezogen auf den Kurs der Aktie der Alibaba Group Holding Limited CH0271423300](https://www.pdfsearch.io/img/fe83a0a21ba4bfb0701284c51c02d0eb.jpg) | Add to Reading ListSource URL: keyinvest-de.ubs.comLanguage: English - Date: 2015-03-08 14:58:46
|
---|
159![Bekanntmachung zu den Endgültigen Bedingungen vom[removed]für UBS Turbo Call/Put Optionsscheine mit den nachfolgenden ISINs bezogen auf den Kurs der Aktie der Alibaba Group Holding Limited CH0271423300 Bekanntmachung zu den Endgültigen Bedingungen vom[removed]für UBS Turbo Call/Put Optionsscheine mit den nachfolgenden ISINs bezogen auf den Kurs der Aktie der Alibaba Group Holding Limited CH0271423300](https://www.pdfsearch.io/img/8f8755b81ab30dc4065f78c3fdfd7aa3.jpg) | Add to Reading ListSource URL: keyinvest-lu.ubs.comLanguage: English - Date: 2015-03-08 14:53:52
|
---|
160![™ Denosumab (Prolia ) STRONG EVIDENCE IN THE CASE AGAINST OSTEOPOROSIS Kristin L. Pareja, Pharm.D. ™ Denosumab (Prolia ) STRONG EVIDENCE IN THE CASE AGAINST OSTEOPOROSIS Kristin L. Pareja, Pharm.D.](https://www.pdfsearch.io/img/207dfe5d34bd36bf1197c2263c9773a6.jpg) | Add to Reading ListSource URL: www.utexas.eduLanguage: English - Date: 2011-01-20 10:06:53
|
---|